Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Mallinckrodt
Citi
Daiichi Sankyo
Farmers Insurance
Queensland Health
Chubb
Chinese Patent Office

Generated: June 19, 2018

DrugPatentWatch Database Preview

Sevoflurane - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for sevoflurane and what is the scope of sevoflurane freedom to operate?

Sevoflurane
is the generic ingredient in three branded drugs marketed by Baxter Hlthcare, Halocarbon Prods, Shanghai Hengrui, Piramal Critical, and Abbvie, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Sevoflurane has forty-four patent family members in thirty-four countries.

There are five drug master file entries for sevoflurane. Five suppliers are listed for this compound.
Pharmacology for sevoflurane
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Synonyms for sevoflurane
(CF3)2CHOCH2F
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)-propane
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
1,1,1,3,3,3-hexakis(fluoranyl)-2-(fluoranylmethoxy)propane
1H,1H,3H-Perfluoro(3-methyl-2-oxabutane)
2,2,2-trifluoro-1-(fluoromethoxy)-1-(trifluoromethyl)ethane
28523-86-6
38LVP0K73A
523F866
A819479
AB01563174_01
AB1010907
AC-15484
AC1L1JU0
AJ-26696
AK122513
AKOS007930500
ANW-42890
AS-13261
Bax 3084
BC209166
BRN 2041023
C07520
C4H3F7O
CAS-28523-86-6
CCG-213707
CHEBI:9130
CHEMBL1200694
CJ-24036
CS0059
CTK4G1651
D00547
D0W6ZF
DB01236
DFEYYRMXOJXZRJ-UHFFFAOYSA-N
DSSTox_CID_26614
DSSTox_GSID_46614
DSSTox_RID_81767
DTXSID8046614
ETHER, FLUOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL-
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
Fluoromethyl1,1,1,3,3,3-HexafluoroisopropylEther
FT-0605909
GTPL7296
H752
HMS3264N21
I14-13357
J-524240
K-7075
KS-000012Q2
LS-67851
MFCD00153189
MolPort-001-775-746
MR_6S4
MR-6S4
MR6S4
NCGC00167421-01
NCGC00167421-02
NSC-760367
NSC760367
OR023816
PC4681
Petrem
Pharmakon1600-01503680
Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
Propane,1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-
RL02970
RTR-012574
SBB092545
SC-80759
SCHEMBL61918
sevoflo
Sevofluran
Sevoflurane (JAN/USAN/INN)
Sevoflurane (JP17/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurane [USAN:USP:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
Sojourn, Ultane, Sevorane
SR-01000944968
SR-01000944968-1
Tox21_112425
TR-012574
Ultane
Ultane (TN)
UNII-38LVP0K73A
ZINC1530810

US Patents and Regulatory Information for sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Critical SOJOURN sevoflurane LIQUID;INHALATION 077867-001 May 2, 2007 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare SEVOFLURANE sevoflurane LIQUID;INHALATION 075895-001 Jul 2, 2002 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shanghai Hengrui SEVOFLURANE sevoflurane LIQUID;INHALATION 203793-001 Nov 3, 2015 AN RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for sevoflurane

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Sign Up ➤ Sign Up
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Sign Up ➤ Sign Up
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for sevoflurane

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,083,514 Polymethylpentene container for an inhalation anesthetic ➤ Sign Up
6,162,443 Container for an inhalation anesthetic ➤ Sign Up
6,558,679 Container for an inhalation anesthetic ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Fuji
Cerilliant
US Department of Justice
Julphar
Queensland Health
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.